Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIMACI: A2A Receptor in Myocardial Ischemia Diagnosis
NCT04640844Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Dosage of adenosine at 24 months. Status: unknown.
Beyond the preview
Go deeper on NCT04640844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04640844.